These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11869545)

  • 41. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
    Ho CH; Chen CL; Li WY; Chen CJ
    Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Observation of apoptosis and proliferation in nasopharyngeal carcinoma].
    Jin O; Feng D; Cheng R
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(5):421-4. PubMed ID: 12080672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The expression of proliferating cell nuclear antigen and Bcl-2 oncoprotein in nasopharyngeal carcinoma].
    Cheng Q; Huang X; Wang J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Apr; 17(4):217-9. PubMed ID: 12838865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma.
    Lu QL; Elia G; Lucas S; Thomas JA
    Int J Cancer; 1993 Jan; 53(1):29-35. PubMed ID: 8380056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Epstein-Barr virus infection and the expression of bcl-2 proto-oncogene in Hodgkin's disease].
    Liu C; Liao S; Gao Z
    Zhonghua Bing Li Xue Za Zhi; 1997 Jun; 26(3):155-7. PubMed ID: 10072857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
    Chen CL; Ou DL
    Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody.
    Brousset P; Butet V; Chittal S; Selves J; Delsol G
    Lab Invest; 1992 Oct; 67(4):457-64. PubMed ID: 1331609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High frequency of latent membrane protein-1 30-bp deletion variant with specific single mutations in Epstein-Barr virus-associated nasopharyngeal carcinoma in Moroccan patients.
    Dardari R; Khyatti M; Cordeiro P; Odda M; ElGueddari B; Hassar M; Menezes J
    Int J Cancer; 2006 Apr; 118(8):1977-83. PubMed ID: 16287066
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression and clinical significance of latent membrane protein-1, matrix metalloproteinase-1 and Ets-1 transcription factor in tunisian nasopharyngeal carcinoma patients.
    Ben Nasr H; Chahed K; Remadi S; Zakhama A; Chouchane L
    Arch Med Res; 2009 Apr; 40(3):196-203. PubMed ID: 19427971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma.
    Yoshizaki T; Endo K; Ren Q; Wakisaka N; Murono S; Kondo S; Sato H; Furukawa M
    Auris Nasus Larynx; 2007 Mar; 34(1):73-8. PubMed ID: 17129696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nasopharyngeal intraepithelial lesion: latent Epstein-Barr virus infection with malignant potential.
    Cheung FM; Pang SW; Yau TK; Chow SK; Lo KW
    Histopathology; 2004 Aug; 45(2):171-9. PubMed ID: 15279636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Interaction between Epstein-Barr virus (EBV) gene expression and antibodies to EBV in nasopharyngeal carcinomas].
    Furukawa M; Nagayama I; Murono S; Takeshita H; Nishimura T; Yoshizaki T
    Rinsho Byori; 1996 Sep; 44(9):832-7. PubMed ID: 8911067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.
    Sheu LF; Chen A; Wei YH; Ho KC; Cheng JY; Meng CL; Lee WH
    Am J Pathol; 1998 Jan; 152(1):63-74. PubMed ID: 9422524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Inhibiting target gene expression and controlling growth of Epstein-Barr virus transformed cells by antisense RNA transcripts].
    Chen JJ; Raab-Traub N; Yao QY; Zhang F; Huang ML; Kuang ZJ; Zhang XS; Ye YL; Gu L
    Ai Zheng; 2002 Jan; 21(1):16-20. PubMed ID: 12500390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bcl-2 and proliferating cell nuclear antigen (PCNA) expression correlates with subsequent local recurrence in nasopharyngeal carcinomas.
    Tsai ST; Jin YT; Leung HW; Wang ST; Tsao CJ; Su IJ
    Anticancer Res; 1998; 18(4B):2849-54. PubMed ID: 9713473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Inhibition of EBV-encoded LMP-1 by DNA-based RNA interference affects metastatic ability of nasopharyngeal carcinoma cells].
    Li G; Li XP; Liu X; Peng Y; Lin MC
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):724-7. PubMed ID: 17366780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epstein-Barr virus latent membrane protein 1 (EBV-LMP1) and tumor proliferation rate as predictive factors of nasopharyngeal cancer (NPC) radiation response.
    Gondhowiardjo S
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():323-31. PubMed ID: 10895175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Internal deletions of the latent membrane protein oncogenes of Epstein-Barr virus in Hodgkin's disease are almost identical with those of Asiatic nasopharyngeal carcinoma].
    Odermatt BF; Heitz PU; Bachmann E; Brousset P; Sandvej K; Knecht H
    Verh Dtsch Ges Pathol; 1994; 78():324-8. PubMed ID: 7534006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analyses of Epstein-Barr virus latent membrane protein-1 in Malaysian nasopharyngeal carcinoma: high prevalence of 30-bp deletion, Xho1 polymorphism and evidence of dual infections.
    Tan EL; Peh SC; Sam CK
    J Med Virol; 2003 Feb; 69(2):251-7. PubMed ID: 12683415
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Apoptosis and apoptosis-related gene expression in nasopharyngeal carcinoma].
    Li J; Tang A; Huang G
    Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):158-60. PubMed ID: 11776648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.